Although opioids remain indispensable for pain relief in patients with advanced cancer, their use frequently results in OIC, ...

Octapharma USA announced that pediatric patients, including children younger than 6 years of age, with von Willebrand Disease (VWD) now have access to routine prophylaxis to help reduce the frequency ...

Allison Wheeler, MD, delves into the complexities of prophylaxis for mild to moderate hemophilia A cases, exploring a patient-centric approach, situational prophylaxis during high-risk activities, and ...

Prophylactic cardiac treatment in DMD patients is associated with a 54% lower hazard of death, highlighting its potential survival benefit. Only 27.7% of DMD patients received prophylactic cardiac ...

Misako Nagasaka, MD, PhD, explains the use of prophylactic anticoagulation for preventing venous thromboembolism (VTE) when administering amivantamab plus lazertinib in patients with EGFR-mutated ...

ORLANDO, Florida ― The aggressive chemotherapy regimen given to children with acute lymphocytic leukemia (ALL) during the induction phase, which aims to push the disease into remission, also depletes ...

Please provide your email address to receive an email when new articles are posted on . Long-term subcutaneous treatment with a C1 inhibitor decreased the frequency and severity of hereditary ...

Before starting cell therapy, patients need more than hope — they need a plan. Dr. Muhammad Tariq breaks down what to expect ...